State Street SPDR S&P Biotech ETF
Management Expense Ratio
0.22%
Annual fee
Dividend Yield
0.34%
Trailing 12-month
Distribution Frequency
Quarterly
Payout schedule
Assets Under Management
$8.3B
Total fund size
Investment Objective
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Still holding bank mutual funds?
The average Canadian bank mutual fund charges a 2.2% MER— that's over 20x more than XBI's fee. Switch to commission-free, self-directed investing and keep more of your returns. Open an account in minutes.
Affiliate disclosure: We may earn a commission at no cost to you.